HO-1 expression correlates with cancer growth and resistance to therapy as shown in different types of tumors such as human renal cell carcinoma [71], prostate and pancreatic cancers [10,72], lymphosarcoma [73], melanoma, and hepatoma [74]. This evidence concerns the gene HMOX1 and hepatocellular carcinoma.